FAM236A

Across TCGA pan-cancer cohorts, FAM236A RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated FAM236A data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher FAM236A RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated FAM236A expression acts as an unfavorable survival marker.

UCS and SARC are the cancer types where FAM236A RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	DFS	Tertile	All	0.068	0.524	<.001	144	view →
SARC	OS	Tertile	All	0.179	0.842	<.001	45	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

FAM236A–UCS (DFS)

Open the UCS breakdown →